PACB

Q: What is the price of Pacific Biosciences (PACB) today?

The price of Pacific Biosciences (PACB) today is $ 1.34, with return of 8.94% compared to the last year. The price of Pacific Biosciences (PACB) started the year trading around $ 1.87 and today it is at $ 1.34. Follow the real-time price chart, the historical price of Pacific Biosciences (PACB) and international markets.

Q: When does Pacific Biosciences (PACB) pay dividends?

Pacific Biosciences (PACB) did not distribute dividends in the last year.

Q: Is Pacific Biosciences (PACB) worth it?

Currently, Pacific Biosciences (PACB) is priced at $ 1.34, with a P/E of -0.74%, representing a deviation of -420% from its historical average P/E. In the last year, the stock showed a variation of 8.94 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was 8.94%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How can I buy Pacific Biosciences (PACB) stock?

Investing in stocks of Pacific Biosciences (PACB) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much would 100 shares of Pacific Biosciences (PACB) yield today?

The yield of Pacific Biosciences (PACB) was -11.84% in the last month, 8.94% in the last year and -96.23% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.If you wanted to buy 100 stocks of Pacific Biosciences (PACB) today, the total investment would be $ 134.00, based on the current price of $ 1.34.If past performance were to repeat, the return on your investment would be:In 1 year: $ 145.98In 5 years: $ 5.05In 10 years: $ 134.00It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Pacific Biosciences of California Inc.

Price

$ 1.34

return (12m)

8.94%

p/e

-0.74

p/bv

75.64

DIVIDEND YIELD

0.00%

PACB price

PACB

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment PACB

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-11.84%

3 months

-27.17%

1 year

8.94%

2 years

-59.76%

5 years

-96.23%

10 years

0.00%

Fundamentals PACB

review the fundamentals of Pacific Biosciences shares

P/E

-0.74

Sector: -4.36 Industry: -13.38

P/S (PSR)

2.53

Sector: 1.79 Industry: 2.90

P/BV

75.64

Sector: 2.09 Industry: 1.79

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

-69.68%

Sector: -30.33% Industry: -67.81%

ROE

-10,212.52%

Sector: -39.83% Industry: -59.34%

ROIC

-36.25%

Sector: -418.66% Industry: -484.72%

NET MARGIN

-100.00%

Sector: -32.52% Industry: -43.03%

GROSS MARGIN

28.61%

Sector: 42.44% Industry: 41.46%

OPERATING MARGIN

-100.00%

Sector: -27.49% Industry: -38.68%

EV/EBITDA

-2.42

Sector: -2.68 Industry: -9.74

EV/EBIT

-0.75

Sector: -3.96 Industry: -11.20

PRICE-TO-ASSETS

0.52

Sector: 1.06 Industry: 1.14

BVPS

0.02

Sector: 3.44 Industry: 1.62

EPS

-1.81

Sector: -1.07 Industry: -1.89

EQUITY-TO-ASSETS RATIO

0.01

Sector: 0.39 Industry: 0.32

LIABILITIES / ASSETS

0.99

Sector: 0.45 Industry: 0.36

CAGR REVENUE 5 YEARS

4.16%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

24.70%

Sector: - Industry: -

Fundamentals PACB

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
LLY	40.57	35.11	86.53%	0.67%	$ 837.34 B	31.66%
ISRG	56.19	8.94	15.92%	0.00%	$ 160.48 B	28.38%
TMO	27.56	3.45	12.52%	0.35%	$ 184.79 B	15.05%
SNY	12.82	1.39	10.86%	4.62%	$ 116.90 B	18.68%
NVS	21.09	6.34	30.04%	4.53%	$ 294.97 B	24.67%
ABT	27.37	3.48	12.73%	2.34%	$ 178.54 B	14.72%
MDT	24.09	2.26	9.38%	3.27%	$ 111.15 B	13.00%
CVS	52.79	1.24	2.35%	3.62%	$ 93.33 B	0.44%
GSK	14.82	5.29	35.71%	2.96%	$ 113.04 B	17.48%
BSX	32.15	0.00	0.00%	0.00%	$ 93.16 B	14.44%
TMDX	17.99	7.24	40.22%	0.00%	$ 3.42 B	31.43%
HCA	15.86	-38.82	-244.82%	0.62%	$ 107.58 B	8.97%
IDXX	43.01	28.38	65.99%	0.00%	$ 45.56 B	24.62%
RMD	22.02	5.18	23.51%	1.04%	$ 32.72 B	27.53%
DHR	37.39	2.57	6.88%	0.67%	$ 135.12 B	14.71%
INMD	9.26	1.27	13.73%	0.00%	$ 868.77 M	25.32%
PHG	24.85	2.00	8.06%	3.27%	$ 25.78 B	5.07%
FMS	11.36	0.77	6.75%	3.51%	$ 12.82 B	5.02%
SYK	39.12	5.66	14.48%	1.03%	$ 126.98 B	12.92%

Stock vs Indice Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

PACB Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Pacific Biosciences

Pacific Biosciences of California Inc.

Average Investor10 user rating

4.0 (3 people)

United States

26 years

Founded: 2000

2010

Time since IPO - 16 years

412

Employees

The Company Pacific Biosciences of California Inc. (United States), is listed on Nasdaq with a market value of $ 404.68 Millions, having an equity of $ 5.35 Millions.

With a total of 412 employees, the company is listed in the sector of Health and categorized in industry of Medical Supplies and Equipment.

In the last 12 months the Company had a revenue of $ 160.01 Millions, which generated a loss in the amount of $ -546.37 Millions.

As for its main indicators, the Company has a P/E ratio of -0.74, a P/BV ratio of 75.64 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker PACB.

Market cap

$ 404.68 Millions

Net worth

$ 5.35 Millions

US$ 5,350,000.00

Assets

$ 784.08 Millions

US$ 784,080,000.00

Total Shares Outstanding

302.00 Millions

302,000,000

Average Daily Trading Volume

$ 6.46 Millions

US$ 6,455,026.94

Sector

Health

Industry

Medical Supplies and Equipment

PACB

PACB revenue and profits

Financial Results PACB

DRAG THE FRAME TO SEE MORE DATA

PACB cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

LBPSW - 4D pharma

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-300.00%

P/BV

0.00

CVS - CVS Health

$ 73.49 20,94% (12M)

P/E

52.79

3.62%

ROE

2.35%

P/BV

1.24

CI - Cigna

$ 270.02 --14,47% (12M)

P/E

10.45

2.26%

ROE

0.00%

P/BV

0.00

CNC - Centene

$ 35.11 --43,31% (12M)

P/E

-2.59

0.00%

ROE

-33.28%

P/BV

0.86

HUM - Humana

$ 177.83 --28,58% (12M)

P/E

17.96

1.99%

ROE

6.70%

P/BV

1.20

HCA - HCA Healthcare

$ 471.84 43,24% (12M)

P/E

15.86

0.62%

ROE

-244.82%

P/BV

-38.82

LLY - Eli Lilly

$ 935.58 30,21% (12M)

P/E

40.57

0.67%

ROE

86.53%

P/BV

35.11

NVS - Novartis

$ 154.03 53,71% (12M)

P/E

21.09

4.53%

ROE

30.04%

P/BV

6.34